跳至主要内容
临床试验/IRCT20190726044339N1
IRCT20190726044339N1招募中2 期

The effect of berberine alkaloid on positive and negative symptoms in patients with schizophrenia: a randomized placebo-controlled double-blind clinical trial

Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
60
The effect of berberine on the symptoms of patients... | 临床试验